UniSuper Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$233M Buy
193,999
+37,627
+24% +$38.4M 1.2% 16
2026
Q1
$144M Sell
156,372
-7,989
-5% -$8.1M 0.94% 18
2025
Q4
$177M Sell
164,361
-426
-0.3% -$407K 1.06% 16
2025
Q3
$126M Buy
164,787
+19,987
+14% +$14.9M 0.77% 19
2025
Q2
$113M Sell
144,800
-16,864
-10% -$13.1M 0.76% 19
2025
Q1
$134M Buy
161,664
+16,982
+12% +$14.1M 1% 17
2024
Q4
$112M Sell
144,682
-5,364
-4% -$4.44M 0.8% 20
2024
Q3
$133M Buy
150,046
+28,526
+23% +$25.6M 1% 17
2024
Q2
$110M Buy
121,520
+45,738
+60% +$36.6M 0.91% 21
2024
Q1
$59M Buy
75,782
+41,456
+121% +$29.5M 0.56% 42
2023
Q4
$20M Sell
34,326
-6,051
-15% -$3.53M 0.22% 96
2023
Q3
$21.7M Buy
40,377
+26,930
+200% +$13.9M 0.27% 88
2023
Q2
$6.31M Buy
+13,447
New +$5.64M 0.07% 164

Other funds holding LLY

UniSuper Management's LLY Position: Q2 2026 in Review

UniSuper Management increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $38.4M and bringing the position to 193,999 shares worth $233M. The position accounts for 1.2% of the portfolio, ranked #16.

UniSuper Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • UniSuper Management held 193,999 shares of Eli Lilly worth $233M as of Q2 2026.
  • UniSuper Management bought 37,627 Eli Lilly shares in Q2 2026, an estimated $38.4M.
  • Eli Lilly made up 1.2% of UniSuper Management's portfolio in Q2 2026, its #16 holding.
  • UniSuper Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.